PT-141

PT-141 (bremelanotide) is a melanocortin agonist studied for sexual desire and arousal through central receptor signaling, with a clearer human-use context than many peptides but still dose-sensitive.

Profile · 01

Overview

PT-141, also known as bremelanotide, is a melanocortin receptor agonist discussed for libido and arousal support. Unlike many peptides in the library, it has a more established human context because bremelanotide has prescription use in specific sexual-health settings.

The source still presents it in a peptide-protocol format with gradual escalation. This page keeps that structure while emphasizing that nausea, flushing, and blood-pressure effects can become practical tolerability limits.

At a Glance

Goal
Support sexual desire and arousal through melanocortin receptor activation
Categories
Sexual HealthLibido EnhancementNeuroendocrine Modulation
Synergistic
Melanotan II · Kisspeptin-10 · DHEA
Profile · 02

Protocol

Suggested once-daily escalating framework presented in the source, though many real-world uses are episodic rather than daily.

Reconstitute
Add 3.0 mL bacteriostatic water to a 10 mg vial for about 3.33 mg/mL concentration
Typical daily range
500-1500 mcg once daily
Start
500 mcg daily for Weeks 1-8
Target
1000-1500 mcg daily by Weeks 9-16
Frequency
Once daily (subcutaneous)
Cycle Length
8-16 weeks with response checks at each titration step
Timing
Any consistent time; rotate injection sites
Route
Subcutaneous
Cycle
8-16 weeks with careful response checks

Inject subcutaneously using conservative dose escalation. The source presents a daily framework, but this compound is often discussed in episodic-use contexts as well. Tolerability, especially nausea and flushing, should guide caution more than the idea that more is better.

Dose progression

Weeks 1-8
500 mcg (0.5 mg) · 15 units (0.15 mL)
Weeks 9-12
1000 mcg (1.0 mg) · 30 units (0.30 mL)
Weeks 13-16
1500 mcg (1.5 mg) · 45 units (0.45 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How PT-141 works.

PT-141 acts through melanocortin receptors rather than nitric-oxide-mediated vasodilation, which is why it is discussed differently from PDE5 inhibitors. The source emphasizes central desire and arousal signaling more than simple mechanical erectile physiology.

Human tolerability and efficacy context is stronger here than in many library entries, but side effects and individual response still vary meaningfully.

Science · 02

Effects

Observations from clinical or preclinical literature.

May support sexual desire and arousal through melanocortin signaling
Mechanistically distinct from PDE5 pathways
Human-use context is stronger than many experimental peptides
Nausea and flushing are common tolerability issues
Blood-pressure changes, headache, or injection-site irritation may occur
Science · 03

Caution

Use caution in uncontrolled hypertension or significant cardiovascular disease
Not recommended during pregnancy or breastfeeding because safety data is insufficient
Use caution with other melanocortin agonists
Do not exceed conservative dosing simply because response is variable

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Sleep
Supports libido, endocrine resilience, and sexual-health outcomes broadly.
Stress reduction
Psychological stress can blunt response even when physiology is addressed.
Hormonal evaluation
Useful context when libido issues involve testosterone, estrogen, or thyroid factors.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Address sleep, relationship context, stress, and broader endocrine health alongside peptide use
Avoid assuming libido challenges are purely one-dimensional
Track response and side effects with context rather than escalating reflexively
Maintain hydration if nausea is an issue
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Libido and arousal response - useful subjective outcome markers
  2. Nausea, flushing, or headache - helpful for titration decisions
  3. Blood pressure and heart rate - especially if cardiovascular sensitivity exists
  4. Injection-site reactions - note redness, swelling, or discomfort
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

Hormone panel
Optional broader context including testosterone, estradiol, or thyroid markers.
CBC (Complete Blood Count)
General baseline and follow-up monitoring.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during the protocol.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 10 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry fully
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites across the abdomen and thighs to reduce local irritation
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile syringe for each injection and dispose of it safely
Nausea and flushing often set the practical ceiling before dose does
Document response, timing, and side effects carefully for consistency
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. FDA / approved-use context
    Bremelanotide clinical and prescribing context.
    https://www.accessdata.fda.gov/
  2. Melanocortin literature
    Human and translational literature on PT-141 / bremelanotide sexual-health effects.
    https://pubmed.ncbi.nlm.nih.gov/
  3. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
On this page